476040 — OrganoidSciences Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩235bn
- KR₩227bn
- KR₩2bn
Annual cashflow statement for OrganoidSciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -17,615 | -24,111 | -38,868 | -11,536 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 12,478 | 14,390 | 30,441 | 827 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -84.1 | 399 | 34.8 | 264 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -4,959 | -8,518 | -7,248 | -9,141 |
| Capital Expenditures | -3,932 | -1,804 | -1,018 | -787 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -52.8 | -26,528 | 5,618 | 5,713 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -3,984 | -28,332 | 4,600 | 4,925 |
| Financing Cash Flow Items | 132 | 218 | 398 | 481 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 32,722 | 11,286 | 180 | 3,663 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 23,779 | -25,563 | -2,543 | -507 |